These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26566491)

  • 21. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway.
    Li X; Meng Y; Xie C; Zhu J; Wang X; Li Y; Geng S; Wu J; Zhong C; Li M
    J Cell Biochem; 2018 May; 119(5):4134-4141. PubMed ID: 29243835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
    Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt/β-catenin pathway.
    Zhu M; Yu X; Zheng Z; Huang J; Yang X; Shi H
    Phytother Res; 2020 Apr; 34(4):817-824. PubMed ID: 31782192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.
    Kaur G; Sharma P; Dogra N; Singh S
    Curr Treat Options Oncol; 2018 Mar; 19(4):20. PubMed ID: 29556842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma.
    Mavila N; Thundimadathil J
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
    Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
    Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
    Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
    Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AGR2 is a target of canonical Wnt/β-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells.
    Dahal Lamichane B; Jung SY; Yun J; Kang S; Kim DY; Lamichane S; Kim YJ; Park JH; Jang WB; Ji ST; Dehua L; Ha JS; Kim YH; Kwon SM
    Biochem Biophys Res Commun; 2019 Aug; 515(4):600-606. PubMed ID: 31178140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling.
    Aminuddin A; Ng PY
    Front Pharmacol; 2016; 7():244. PubMed ID: 27570510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt Signaling in Cancer Metabolism and Immunity.
    El-Sahli S; Xie Y; Wang L; Liu S
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
    Bordonaro M; Lazarova DL
    World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.
    Satriyo PB; Bamodu OA; Chen JH; Aryandono T; Haryana SM; Yeh CT; Chao TY
    J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30691241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
    Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.